Telehealth program to prevent HIV and treat hepatitis C for people who inject drugs
Part of Digestive system, Infections, Mental health clinical trials.
This study tests a telehealth program to help people who inject drugs in rural Southern areas prevent HIV and get care for hepatitis C. It's designed to be supportive and help you build strength to stay healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You currently inject drugs (like heroin or fentanyl).
- You do NOT have HIV (you are HIV-negative).
- You are 18 years old or older.
- You live in a rural area (not a big city).
- You can speak and understand English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This project studies how to improve offering and completing HIV (and hepatitis C) tests in opioid treatment programs. It may help increase timely follow-up and linkage to care when results are positive.
This study tests a program to help people living with HIV in Alabama who also struggle with opioid or stimulant use. It takes place at your HIV clinic and checks whether a new approach to addiction care can improve your health.
This study tests an integrated phone-based health program (e-health) designed for women involved with the justice system who have opioid use disorder. It aims to help people who qualify for HIV prevention (PrEP) stay protected, especially by using simple, ongoing support through phone access.
This study tests whether a tailored telehealth program can help people with opioid use disorder get better access to treatment. It is designed for patients who are already receiving or starting treatment with buprenorphine at Prevention Point Philadelphia.
This study tests whether having your injecting partner help support you after hepatitis C treatment keeps you more engaged with healthcare. Researchers will check in with you and your partner a few months after your treatment ends to see if extra support helps.
This study helps people who inject drugs start HIV prevention (PrEP) and medication for opioid use disorder (MOUD) faster. It may reduce HIV risk and improve access to treatment, while the study checks whether the “rapid access” approach works.
Hear when a new HIV Pre-exposure Prophylaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.